ZA967833B - Method and composition for treating mammalian diseases caused by inflammatory response - Google Patents
Method and composition for treating mammalian diseases caused by inflammatory responseInfo
- Publication number
- ZA967833B ZA967833B ZA967833A ZA967833A ZA967833B ZA 967833 B ZA967833 B ZA 967833B ZA 967833 A ZA967833 A ZA 967833A ZA 967833 A ZA967833 A ZA 967833A ZA 967833 B ZA967833 B ZA 967833B
- Authority
- ZA
- South Africa
- Prior art keywords
- composition
- inflammatory response
- diseases caused
- treating mammalian
- mammalian diseases
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US396295P | 1995-09-19 | 1995-09-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA967833B true ZA967833B (en) | 1997-06-02 |
Family
ID=21708422
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA967833A ZA967833B (en) | 1995-09-19 | 1996-09-17 | Method and composition for treating mammalian diseases caused by inflammatory response |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0804181A4 (en) |
JP (1) | JP4459303B2 (en) |
AU (1) | AU719332B2 (en) |
CA (1) | CA2205112C (en) |
IL (1) | IL119225A (en) |
MX (1) | MX9703653A (en) |
NZ (1) | NZ306832A (en) |
TW (1) | TW434012B (en) |
WO (1) | WO1997010818A1 (en) |
ZA (1) | ZA967833B (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4885362B2 (en) * | 1999-05-14 | 2012-02-29 | セルラー サイエンセズ インコーポレイテッド | Methods and compositions for treating nasal and sinus diseases of mammals caused by an inflammatory response |
JP2004528307A (en) * | 2001-03-15 | 2004-09-16 | ユニバーシティ オブ ピッツバーグ オブ ザ コモンウェルス システム オブ ハイヤー エデュケーション | Use of pyruvate and / or derivatives thereof for the treatment of inflammatory conditions mediated by cytokines |
US6689810B2 (en) * | 2001-08-21 | 2004-02-10 | Cellular Sciences, Inc. | Method for treating pulmonary disease states in mammals by altering indigenous in vivo levels of nitric oxide |
US6623723B2 (en) * | 2001-08-21 | 2003-09-23 | Cellular Sciences Inc. | Method for treating bronchial constriction and bronchospasm |
US20030105162A1 (en) * | 2001-08-21 | 2003-06-05 | Celluar Sciences, Inc. | Method for treating bronchial constriction and bronchospasm |
US8076373B2 (en) * | 2001-09-11 | 2011-12-13 | North Cell Pharmacetical | Method for treating mammalian diseases and injuries caused by the over-expression of peroxynitrite |
JP5630750B2 (en) * | 2008-03-18 | 2014-11-26 | 国立大学法人 岡山大学 | Excitatory chemical transmission regulator and screening method thereof |
WO2018232383A1 (en) * | 2017-06-16 | 2018-12-20 | Vanderbilt University | Methods and compositions for treating microbial inflammation |
US11571455B2 (en) | 2013-04-11 | 2023-02-07 | Vanderbilt University | Methods and compositions for treating alcoholic liver disease |
EP3797766A1 (en) * | 2019-09-24 | 2021-03-31 | Evonik Operations GmbH | Compositions for use in reducing inflammation |
EP4058556A1 (en) * | 2019-11-14 | 2022-09-21 | Merck Patent GmbH | Cell culture media |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1857M (en) * | 1962-03-08 | 1963-06-10 | Roussel Uclaf | New drug in particular for the treatment of diseases of viral origin. |
US3279997A (en) * | 1963-10-22 | 1966-10-18 | Herbert D Schneyer | Enteric coated calcium lactate tablets containing an antihistamine and thiamine chloride |
US3879537A (en) * | 1973-09-04 | 1975-04-22 | Scott Eugene J Van | Treatment of ichthyosiform dermatoses |
US3988470A (en) * | 1974-02-25 | 1976-10-26 | Scott Eugene J Van | Treatment of palmar and plant disturbed keratosis |
US4158057A (en) * | 1975-03-28 | 1979-06-12 | Stanko Ronald T | Prevention of the accumulation of fatty deposits in the liver |
US4021572A (en) * | 1975-07-23 | 1977-05-03 | Scott Eugene J Van | Prophylactic and therapeutic treatment of acne vulgaris utilizing lactamides and quaternary ammonium lactates |
US4197316A (en) * | 1975-07-23 | 1980-04-08 | Scott Eugene J Van | Treatment of dry skin |
US4234599A (en) * | 1978-10-04 | 1980-11-18 | Scott Eugene J Van | Treatment of skin keratoses with α-hydroxy acids and related compounds |
US4351835A (en) * | 1981-04-01 | 1982-09-28 | Montefiore Hospital | Method for preventing body fat deposition in mammals |
US4415576A (en) * | 1981-04-01 | 1983-11-15 | Montefiore Hospital | Method for preventing body fat deposition in mammals |
US4521375A (en) * | 1982-11-23 | 1985-06-04 | Coopervision, Inc. | Sterilizing treatment with hydrogen peroxide and neutralization of residual amounts thereof |
DE3302694A1 (en) * | 1983-01-27 | 1984-08-02 | Retheto Filmtechnik Theilemann & Co, 8000 München | ORAL CARE PRODUCTS |
AU4634685A (en) * | 1984-06-22 | 1986-01-24 | R.L. Veech | Electrolyte solutions and in vivo use thereof |
US4696917A (en) * | 1985-08-01 | 1987-09-29 | Lindstrom Richard L | Irrigation solution |
JPS63135370A (en) * | 1986-11-26 | 1988-06-07 | Grelan Pharmaceut Co Ltd | Antiallergic agent |
IN168530B (en) * | 1987-11-06 | 1991-04-20 | Lyphomed Inc | |
AU4056089A (en) * | 1988-07-20 | 1990-02-19 | Amgen, Inc. | Method of treating inflammatory disorders by reducing phagocyte activation |
JP2794021B2 (en) * | 1988-11-02 | 1998-09-03 | エーザイ株式会社 | Transdermal preparation containing azelastine or its salts |
AU7699191A (en) * | 1990-03-30 | 1991-10-30 | Amgen, Inc. | Respiratory burst suppression factor |
US5210098A (en) * | 1990-09-21 | 1993-05-11 | Regents Of The University Of Minnesota | Use of pyruvate to treat acute renal failure |
US5296370A (en) * | 1990-10-04 | 1994-03-22 | Rutgers, The State University | Repair medium for the resuscitation of injured cells |
US5648380A (en) * | 1991-03-01 | 1997-07-15 | Warner-Lambert Company | Anti-inflammatory wound healing compositions and methods for preparing and using same |
WO1993016690A1 (en) * | 1992-02-25 | 1993-09-02 | Warner-Lambert Company | Cytoprotective compositions containing pyruvate and antioxidants |
US5256697A (en) * | 1992-04-16 | 1993-10-26 | Abbott Laboratories | Method of administering pyruvate and methods of synthesizing pyruvate precursors |
JP3236658B2 (en) * | 1992-04-27 | 2001-12-10 | 花王株式会社 | Bronchodilator |
US5536751A (en) * | 1994-05-09 | 1996-07-16 | The United States Of America As Represented By The Secretary Of The Army | Pharmaceutical alpha-keto carboxylic acid compositions method of making and use thereof |
-
1996
- 1996-09-06 NZ NZ306832A patent/NZ306832A/en not_active IP Right Cessation
- 1996-09-06 EP EP96929932A patent/EP0804181A4/en not_active Withdrawn
- 1996-09-06 WO PCT/US1996/014304 patent/WO1997010818A1/en active Application Filing
- 1996-09-06 AU AU69159/96A patent/AU719332B2/en not_active Ceased
- 1996-09-06 MX MX9703653A patent/MX9703653A/en unknown
- 1996-09-06 CA CA002205112A patent/CA2205112C/en not_active Expired - Lifetime
- 1996-09-06 JP JP51274197A patent/JP4459303B2/en not_active Expired - Lifetime
- 1996-09-09 IL IL11922596A patent/IL119225A/en not_active IP Right Cessation
- 1996-09-17 ZA ZA967833A patent/ZA967833B/en unknown
- 1996-09-18 TW TW085111379A patent/TW434012B/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA2205112A1 (en) | 1997-03-27 |
EP0804181A1 (en) | 1997-11-05 |
TW434012B (en) | 2001-05-16 |
CA2205112C (en) | 2008-11-18 |
EP0804181A4 (en) | 2005-02-02 |
JP4459303B2 (en) | 2010-04-28 |
MX9703653A (en) | 1998-07-31 |
IL119225A0 (en) | 1996-12-05 |
WO1997010818A1 (en) | 1997-03-27 |
AU6915996A (en) | 1997-04-09 |
NZ306832A (en) | 2001-04-27 |
IL119225A (en) | 2000-09-28 |
JPH10509463A (en) | 1998-09-14 |
AU719332B2 (en) | 2000-05-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU695664B2 (en) | Method for treating cardiac inflammatory disease | |
CY2178B1 (en) | Naphthyl compounds intermediates compositions and methods | |
IL123166A0 (en) | Method and composition for treating asthma | |
PL323258A1 (en) | Novel method of controlling biological degradation | |
AU642762B2 (en) | Method of treating inflammatory bowel disease | |
AU4017395A (en) | Method for treating anxiety | |
IL97973A0 (en) | Composition and method for controlling cholesterol | |
NO981403D0 (en) | Method and composition for controlling frogs using amides | |
GB2298713B (en) | Method and composition | |
PL314996A1 (en) | Kappa-opiatagonistic agents for treating intestinal inflammatory diseases | |
PL318193A1 (en) | Novel streptogramines and method of obtaining them by mutasynthesis | |
AU1074397A (en) | Method for treating anxiety | |
ZA967833B (en) | Method and composition for treating mammalian diseases caused by inflammatory response | |
IL119817A (en) | Liquid-absorbent article and method for its manufacture | |
PL327439A1 (en) | Microbiological method of 11alpha- hydroxylating the steroids | |
ZA961226B (en) | An apparatus and method to manufacture cast panels | |
AU7726396A (en) | Method for treating anxiety | |
GB9410345D0 (en) | Method of genetic testing | |
AU7674796A (en) | Method for treating anxiety | |
IL125043A0 (en) | Iminooxyphenylacetic acid derivatives method and intermediates for their preparation and their use | |
HUP9602938A2 (en) | Improved composition and method for acid gas treatment | |
AU9087591A (en) | Composition and method for treating metal | |
AU4017195A (en) | Method for treating anxiety | |
AU7999691A (en) | Phthalamic acids and their isomers for treating leukotriene-related diseases | |
GB9513552D0 (en) | Method and composition for treating atopic eczema |